Chief Operating Officer, Rentschler Biopharma
Christiane Bardroff is an expert and truly inspiring leader in clinical and commercial biopharmaceutical development, manufacturing, automation, and project management. She has experience navigating multiple international regulatory bodies, including execution of audits and inspections, in support of global release of pharmaceutical marked products. As a leader in manufacturing, process science, engineering, supply chain, and quality, Christiane interfaces between company and client to ensure superior outcomes for complex biopharmaceutical projects. Previously she worked for Roche and Teva in several management positions. Christiane studied biotechnology and chemical engineering at Emden University of Applied Sciences in Germany and Zhejiang University of Science and Technology in Hangzhou, China. Learn more at Rentschler-Biopharma.com.
Talk to Christiane about these topics and more:
- Process development and cGMP manufacturing for clinical and commercial biopharmaceuticals
- Navigating international regulatory bodies for global pharmaceutical product releases
- Nurturing collaborative relationships with client partners to accelerate speed to clinic and market
- Automation and digitalization in biopharmaceutical manufacturing
- Trends and predictions in the biopharmaceutical industry
Ready to Connect?
Would you like to invite a health science expert to participate in your next piece, program, panel, or partnership? Our team is standing by to help connect you to the right source and topic:
About Rentschler Biopharma
Rentschler Biopharma is a leading contract development and manufacturing organization (CDMO) focused exclusively on client projects. The company offers process development and manufacturing of biopharmaceuticals as well as related consulting activities, including project management and regulatory support. Rentschler Biopharma’s high quality is proven by its long-standing experience and excellence as a solution partner for its clients. A high-level quality management system, a well-established operational excellence philosophy, and advanced technologies ensure product quality and productivity at each development and manufacturing step. Rentschler Biopharma is a family-owned company with about 1,200 employees, headquartered in Laupheim, Germany, with a second site in Milford, MA, USA. Adjacent to its existing facility in Milford, the company has undertaken the largest expansion in its long history of 150 years. The state-of-the-art Rentschler Biopharma Manufacturing Center (RBMC) will add 22,000 square feet of manufacturing cleanroom space and house four new 2,000 L single-use bioreactors. In Stevenage, U.K., Rentschler Biopharma has launched a company dedicated to cell and gene therapies, Rentschler ATMP. Visit Rentschler-Biopharma.com.